{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:10:25Z","timestamp":1740107425736,"version":"3.37.3"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s00393-020-00896-y","type":"journal-article","created":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T17:02:54Z","timestamp":1601571774000},"page":"73-77","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Thrombopenie und Thrombosen bei einer jungen Frau","Thrombocytopenia and thromboses in a young woman"],"prefix":"10.1007","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5662-0888","authenticated-orcid":false,"given":"S.","family":"Tatsis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Malkowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"G\u00fcldenzoph","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,10,1]]},"reference":[{"key":"896_CR1","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/cyto.b.20525","volume":"78","author":"MJ Borowitz","year":"2010","unstructured":"Borowitz\u00a0MJ, Craiq\u00a0FE, Digiuseppe\u00a0JA et\u00a0al (2010) Guidelines for the diagnosis and monitoring of paroxysmal nocturnal hemoglobinuria and related disorders by flow cytometry. Cytometry B Clin Cytom 78:211\u2013230","journal-title":"Cytometry B Clin Cytom"},{"issue":"18","key":"896_CR2","doi-asserted-by":"publisher","first-page":"2804","DOI":"10.1182\/blood-2014-02-522128","volume":"124","author":"RA Brodsky","year":"2014","unstructured":"Brodsky\u00a0RA (2014) Paroxysmal nocturnal hemoglobinuria. Blood 124(18):2804\u20132811","journal-title":"Blood"},{"key":"896_CR3","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/978-90-481-9485-8_22","volume":"686","author":"B Gulbis","year":"2010","unstructured":"Gulbis\u00a0B, Eleftheriou\u00a0A, Angastiniotis\u00a0M et\u00a0al (2010) Epidemiology of rare anaemias in Europe. Adv Exp Med Biol 686:375\u2013396","journal-title":"Adv Exp Med Biol"},{"key":"896_CR4","doi-asserted-by":"publisher","first-page":"4985","DOI":"10.1182\/blood-2012-09-311381","volume":"121","author":"A Hill","year":"2013","unstructured":"Hill\u00a0A, Kelly\u00a0RJ, Hillmen\u00a0P (2013) Thrombosis in paroxysmal nocturnal hemoglobinuria. Blood 121:4985\u20134996","journal-title":"Blood"},{"key":"896_CR5","doi-asserted-by":"publisher","first-page":"5123","DOI":"10.1172\/JCI123501","volume":"129","author":"B H\u00f6chsmann","year":"2019","unstructured":"H\u00f6chsmann\u00a0B, Murakami\u00a0Y, Osato\u00a0M et\u00a0al (2019) Complement and inflammasome overactivation mediates paroxysmal nocturnal hemoglobinuria with autoinflammation. J\u00a0Clin Invest 129:5123\u20135136","journal-title":"J Clin Invest"},{"key":"896_CR6","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1111\/ejh.13176","volume":"102","author":"CJ Patriquin","year":"2019","unstructured":"Patriquin\u00a0CJ, Kiss\u00a0T, Caplan\u00a0S et\u00a0al (2019) How we treat paroxysmal nocturnal hemoglobinuria: a consensus statement of the Canadian PNH Network and review of the national registry. Eur J Haematol 102:36\u201352","journal-title":"Eur J Haematol"},{"issue":"12","key":"896_CR7","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1182\/blood-2005-04-1717","volume":"106","author":"C Parker","year":"2005","unstructured":"Parker\u00a0C, Omine\u00a0M, Richards\u00a0S et\u00a0al (2005) International PNH Interest Group. Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood 106(12):3699\u20133709","journal-title":"Blood"},{"issue":"1157","key":"896_CR8","first-page":"1","volume":"10","author":"A Risitano","year":"2019","unstructured":"Risitano\u00a0A, Marotta\u00a0S, Marano\u00a0L et al (2019) Anti-complement treatment for paroxysmal nocturnal hemoglobinuria: time for proximal complement inhibition? A position paper from the SAAWP of the EBMT. Fimmu 10(1157):1\u201324","journal-title":"Fimmu"},{"key":"896_CR9","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1038\/nbt1344","volume":"25","author":"RP Rother","year":"2007","unstructured":"Rother\u00a0RP, Rollins\u00a0SA, Mojcik\u00a0CF et\u00a0al (2007) Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria. Nat Biotechnol 25:1256\u20131264","journal-title":"Nat Biotechnol"},{"issue":"5","key":"896_CR10","doi-asserted-by":"publisher","first-page":"922","DOI":"10.3324\/haematol.2013.093161","volume":"99","author":"H Schrezenmeier","year":"2014","unstructured":"Schrezenmeier\u00a0H, Muus\u00a0P, Socie\u00a0G et\u00a0al (2014) Baseline characteristics and disease burden in patients in the International Paroxysmal Nocturnal Hemoglobinuria Registry. Haematologica 99(5):922\u2013929","journal-title":"Haematologica"},{"issue":"4","key":"896_CR11","doi-asserted-by":"publisher","first-page":"e0195909","DOI":"10.1371\/journal.pone.0195909","volume":"13","author":"D Sheridan","year":"2018","unstructured":"Sheridan\u00a0D, Yu\u00a0ZX, Zang\u00a0Y et al (2018) Design and preclinical characterization of ALXN1210: a\u00a0novel anti-C5 antibody with extended duration action. PLoS ONE 13(4):e0195909","journal-title":"PLoS ONE"},{"key":"896_CR12","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/0092-8674(93)90250-T","volume":"73","author":"J Takeda","year":"1993","unstructured":"Takeda\u00a0J, Miyata\u00a0T, Kawagoe\u00a0K et al (1993) Deficiency of the GPI anchor caused by somatic mutation of the PIG\u2011A gene in paroxysmal nocturnal hemoglobinuria. Cell 73:703\u2013711","journal-title":"Cell"},{"key":"896_CR13","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2147\/ODRR.S73641","volume":"5","author":"IC Weitz","year":"2015","unstructured":"Weitz\u00a0IC (2015) Paroxysmal nocturnal hemoglobinuria: new concepts in pathophysiology and treatment. Orphan Drugs:research Rev 5:75\u201381","journal-title":"Orphan Drugs:research Rev"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-020-00896-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00393-020-00896-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-020-00896-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T03:50:29Z","timestamp":1698205829000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00393-020-00896-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,1]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["896"],"URL":"https:\/\/doi.org\/10.1007\/s00393-020-00896-y","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"type":"print","value":"0340-1855"},{"type":"electronic","value":"1435-1250"}],"subject":[],"published":{"date-parts":[[2020,10,1]]},"assertion":[{"value":"5 September 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"S.\u00a0Tatsis, L.\u00a0Malkowski und B.\u00a0G\u00fcldenzoph geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}